Two non-drug, device approaches to tackling the opioid crisis
Companies are developing non-drug approaches to tackling the prescription opioid crisis and stand to receive support from the likes of the NIH and the FDA.
Companies are developing non-drug approaches to tackling the prescription opioid crisis and stand to receive support from the likes of the NIH and the FDA.
Flex, a global electronics contract manufacturer, is reshaping itself to grow its $2 billion healthcare business and believes its take on the future will help traditional medtech companies fare better.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.